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Purpose: Proliferation of lens epithelial cell (LEC) is main principle for posterior capsular opacity (PCO) following
surgery. We investigated whether overexpression of Krüppel-like factor 6 (KLF6) can be employed to increase protein
21 (p21) and protein 27 kinase inhibition protein 1 (p27 kip1) levels and its effect on proliferation of LEC.
Methods: A plasmid containing KLF6 cDNA was used to increase the level of KLF6 protein in rat lens epithelial cells
(rLEC) which can lead to consequent degradation of p21 and p27 kip1. Cell proliferation was assayed by cell counts and
bromodeoxyuridine (BrdU) Incorporation.
Results: western blot analysis showed increased levels of KLF6, p21, and p27kip1 in cells transfected with pKLF6 cDNA.
pKLF6 cDNA transfected cells showed less compared with control cells in vitro.
Conclusions: pKLF6 cDNA inhibited cell proliferation and decreased cell viability of LEC by unregulation of p21 and
p27 kip1.
Posterior  capsular  opacification  (PCO),  which  is  also
termed  secondary  cataract,  is  a  common  long-term
complication of modern cataract surgery [1]. At present, the
only  effective  treatment  of  PCO  is  Nd:YAG  laser
capsulotomy,  which  involves  clearing  the  visual  axis  by
creating a central opening in the opacified posterior capsule
[2,3].
The tumor suppressor Krüppel-like factor 6 (KLF6) is a
member of the Kruppel-like zinc finger transcription factor
family  of  proteins,  which  are  involved  in  regulating
differentiation, development, cellular proliferation, growth-
related signal transduction, and apoptosis.
KLFs are a subclass of the zinc finger family of DNA-
binding  transcription  factors.  KLF6  (also  known  as  core
promoter element binding protein [COPEB] or GC-rich sites
binding factor [GBF]) was independently cloned from liver,
placenta, and leukocyte cDNA libraries by several groups
[4-7]. KLF6 was initially shown to be rapidly induced in
activated hepatic stellate cells, the key fibrogenic cell type in
liver injury and repair, implicating this factor as playing a role
in tissue injury.
In  present  study,  we  examined  if  transfection  with
KLF6 cDNA could upregulate protein 21 (p21) and protein 27
kinase inhibition protein 1 (p27kip1) in rat LEC (rLEC) and
their effect on rLEC proliferation in vitro.
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METHODS
Reagents: KLF6, p21, and p27 kip1 antibody were purchased
from  Santa  Cruz  biotechnology  Inc.,  (Santa  Cruz,  CA).
Dulbecco’s  modified  Eagle’s  medium  medium  (DMEM),
streptomycin,  and  penicillin  were  purchased  from  Gibco
(Carlsbad,  CA).  Fetal  calf  serum  was  purchased  from
Invitrogen (Carlsbad, CA). Hanks solution was purchased
from Hyclone (Logan, UT). Poly-lysine was purchased from
Sigma (St. louis, MO). Culture plates were purchased from
BD Biosciences (San Jose, CA). Hybond-P polyvinylidene
difluoride (PVDF) membrane was purchased from Amersham
Pharmacia  Biotech  (Piscataway,  NJ).
Methylthiazolyltetrazolium  (MTT)  was  purchased  from
Sigma.  MTT  cell  proliferation  kits  were  purchased  from
ATCC (Manassas, VA). The Cell Counter was purchased
from Coulter (Z1; Jacksonville, FL).
Cell culture of rLEC: All experimental procedures were in
accordance with our institutional guidelines for animal care
and  the  Guide  for  Care  and  Use  of  Laboratory  Animals
published  by  the  US  National  Institutes  of  Health  (NIH
publication no. 85–23, revised 1996).
The  Wistar  rats  (Harbin  Huakang  company,  Harbin,
Heilongjiang province, China) used in this investigation were
handled in according to the tenets of the ARVO Statement for
the Use of Animals in Ophthalmic and Vision Research. Six-
week-old rats were killed by CO2 inhalation. The entire eye
was removed and dipped in 75% ethanol for 30 s, and then it
was  opened  from  the  posterior  segment.  The  dissection
procedure was performed with sterile instruments under a
laminar  flow  hood.  Lenses  were  carefully  dissected  by  a
posterior  approach  and  washed  three  times  in  phosphate-
buffered  saline  (PBS)  to  remove  attached  pigments  and
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1080vitreous. The capsule epithelium was dissected by fine forceps
and placed in a 35 mm2 culture dish where it adhered to the
plastic. Some drops of culture medium were applied to the
epithelium specimens to prevent drying, and the dishes were
put in a humidified CO2 incubator (5% CO2, 37 °C) for 6 h to
allow firm attachment of the capsules. Another 2 ml of culture
medium was then added, and the capsules were left for 3 or 4
days  before  the  first  trypsinization  and  subculturing.  The
medium, which was changed every 2 days, was DMEM with
20% fetal bovine serum (FBS), supplemented with 2 mM L-
glutamine, 100 U/ml penicillin and 100 μg/ml streptomycin.
rLECs were cultured in a six-well plate with a sterile
coverslip. All culture media were modified Eagle's medium
with 10% fetal bovine serum (FBS), supplemented with 2 mM
L-glutamine,  100  U/ml  penicillin  and  100  μg/ml
streptomycin.  Cells  used  in  subsequent  experiments  were
generally from passages two to three. All cells were grown at
37 °C with 5% CO2 ventilation [8].
KLF6 overexpression plasmid construct: To enforce KLF6
expression in the cells, the full-length cDNA (852 bp) of
KLF6 containing NheI and XhoI restriction digestive sites at
both  ends  was  amplified  using  a  PfuUltra  Hotstart  DNA
Polymerase Kit (Biocompare company, Palo Alto, CA). The
amplified KLF6 DNA fragment was subsequently cloned into
a pTRE vector (Takara Bio Inc, Otsu, Shiga) [9].
rLEC transfected with plasmid containing KLF6 cDNA,
empty vector only, and medium served as the experimental
group,  vehicle  control  group,  and  blank  control  group,
respectively. Transfection was performed in 60 mm plates
using 3µg (1 µg/µl) vector in 10 µl of Metafectene Pro reagent
(Biontex, Martinstried, Germany). After 48 h of transfection,
cells were treated with G418 (Life Technologies, Carlsbad,
CA) for 2 weeks for positive clone selection. After G418
treatment, several stable transfectant cells were cloned. Each
clone was screened for expression of KLF6 by western blot
analysis.
Western blot analysis: rLEC were separately by ultrasonic
disruption in a lysis buffer. Protein Protein concentration was
measured  using  absorbance  spectroscopy.  Protein  was
separated on a 10% SDS-polyacrylamide gel and transferred
to a PVDF membrane (Biocompare company, Palo Alto, CA).
After blocking with 5% nonfat milk, the membranes were
incubated with primary antibodies against KLF6, p21, and
p27  kip1 (Santa Cruz biotechnology Inc., Santa Cruz, CA)
overnight at 4 °C, followed by incubation with secondary
antibodies (Santa Cruz biotechnology Inc.). Densitometry of
the bands was performed with quantity one analysis software.
Cell  proliferation  and  bromodeoxyuridine  (BrdU)
incorporation: For bromodeoxyuridine (BrdU) incorporation,
rLEC  cells  growing  on  coverslips  were  fixed  with  4%
paraformaldehyde in vitro for 30 min at 4 °C and washed in
0.1M PBS (pH 7.4) with 1% Triton. The cells were then
incubated in HCl (1 N) for 10 min on ice followed by HCl (2
N) for 10 min at room temperature, followed by incubating
overnight  with  anti-BrdU  or  a  combination  of  anti-BrdU
antibody  and  then  treated  with  secondary  antibodies  to
visualize  the  anti-BrdU  labeled  cells.  The  nuclei  were
simultaneously stained with 10 µg/ml of 4V, 6-diamidino-2-
phenylindole.  Cells  with  different  BrdU-incorporation
patterns were analyzed and counted with a traditional light
microscope (CX21, Olympus Inc, Tokyo, Japan) [8].
Statistical analysis: The data were analyzed by the two-tailed
Student t-test using SPSS (IBM Inc, Beijing, China) 10.0 and
p<0.05 was considered significance.
RESULTS
Upregulation of KLF6 protein by pKLF6 cDNA in rLEC:
KLF6 expression can be detected in rLEC’s compared to the
vehicle control group and blank control group (Figure 1, lane
1 and 2) in vitro. However, there was increased expression of
KLF6  in  the  experimental  group,  which  indicated  that
transfection with pKLF6 cDNA can increase expression of
KLF6 in rLEC (Figure 1, lane 3) in vitro.
Upregulation of p21 in rSF transfected with pKLF6 cDNA:
Little expression of p21 protein in the rLEC transfected with
vehicle (Figure 2, lane 1) or without transfection (Figure 2,
lane 2). Upregulation of p21 was detected in rLEC transfected
with pKLF6 cDNA (Figure 2, lane 3).
Upregulation of p27kip1 in rSF transfected with pKLF6 cDNA:
Expression  of  p27kip1  increased  in  rLEC  transfected  with
pKLF6 cDNA (Figure 3, lane 2) compared with the blank
control (Figure 3, lane 3) and vehicle control (Figure 3, lane
1).
Figure 1. Upregulation of KLF6 protein by pKLF6 cDNA in rLEC.
KLF6 expression can be detected in rLEC’s compared to the vehicle
control  group  and  blank  control  group  (lane  1  and  2)  in  vitro.
However,  there  was  increased  expression  of  KLF6  in  the
experimental group, which indicated that transfection with pKLF6
cDNA can increase expression of KLF6 in rLEC (lane 3) in vitro.
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) served as a
loading control.
Molecular Vision 2011; 17:1080-1084 <http://www.molvis.org/molvis/v17/a122> © 2011 Molecular Vision
1081Incorparation  of  Brdu:  Expression  of  BrdU  decreased  in
pKLF6 cDNA transfectant cells (Figure 4C). compared with
rLEC of vehicle control (Figure 4A) and blank control (Figure
4 B) after cell counting showed that Brdu positive cells in
rLEC transfected with pKLF6 cDNA significantly decreased
compared with control cells (p<0.01 versus vehicle and blank
control; Figure 4D).
DISCUSSION
Lens epithelial cells (LECs) left behind in the capsular bag
after any type of extracapsular cataract surgery are mainly
responsible  for  PCO  development  [10].  Proliferation,
migration,  epithelial-to-mesenchymal  transition  (EMT),
collagen deposition, and lens fiber regeneration of LECs are
the main causes of opacification
Figure 2. Upregulation of p21 in rSF transfected with pKLF6 cDNA.
Little expression of p21 protein in the rLEC transfected with vehicle
(lane 1) or without transfection (lane 2). Upregulation of p21 was
detected in rLEC transfected with pKLF6 cDNA (lane 3). GAPDH
served as loading control.
Figure 3. Upregulation of p27kip1 in rSF transfected with pKLF6
cDNA. Expression of p27kip1 increased in rLEC transfected with
pKLF6 cDNA (lane 2) compared with the blank control (lane 3) or
vehicle control (lane 1). GAPDH served as loading control.
Fibrosis-type  PCO  is  caused  by  the  proliferation  and
migration of LECs, which undergo EMT, resulting in fibrous
metaplasia and leading to significant visual loss by producing
folds and wrinkles in the posterior capsule [11]. Pearl-type
PCO is caused by the LECs located at the equatorial lens
region  (lens  bow)  causing  regeneration  of  crystallin-
expressing lenticular fibers and forming Elschnig pearls and
Soemmering ring, responsible for most cases of PCO-related
visual loss [12].
There are several urgent reasons to eradicate PCO. First,
PCO  remains  the  most  common  complication  of  cataract
surgery [13,14]. Posterior capsular opacification is even more
threatening  in  young  adults  and  children,  with  a  higher
incidence,  quicker  onset,  and  greater  amblyogenic  effect.
Migration of human LECs plays an important role in the
remodeling of the lens capsule [15,16] and is associated with
matrix  metalloproteinase  activity  in  the  lens  [17].  Matrix
metalloproteinases  are  a  group  of  proteolytic  enzymes,
essential for cell migration and cell-mediated contraction after
wound healing [18].
KLF6  (Kruppel-like  factor  6)  is  a  tumor  suppressor
protein that is down-regulated or mutated in several types of
cancers, including prostate cancer [19-21]. KLF6 is a zinc
finger transcription factor that binds to a GC box and regulates
the expression of target genes. It has been shown that KLF6
suppresses tumor growth through activating protein 21 wild-
type  activated  fragment  1/cyclin  inhibitor  protein  1  (p21
WAF1/Cip1), an inhibitor of the cyclin-dependent kinases, in
both cultured cells and a transgenic mouse model [22]. KLF6
also  directly  interacts  with  cyclin  D1  to  suppress  cyclin-
dependent kinase 4 and causes cell cycle arrest [23].
Of particular note with respect to potential therapeutic
targeting  are  our  studies  demonstrating  not  only  that
overexpression of KLF6-SV1 is associated with decreased
survival and metastatic spread of certain cancers but also that
siRNA-mediated inhibition of KLF6-SV1 has such dramatic
effects on tumor behavior in vitro and in vivo [24-26].
Our previous result indicated that s-phase kinase protein
2 (skp2) siRNA can inhibit proliferation of proliferation of
rLEC and cell viability decreased from the 6th day to the 12th
day after transfection. Skp2 siRNA transfection also increased
expression of p27kip1. p27kip1 is important for regulation of cell
cycle. Our present data showed that tansfection with pKLF6
cDNA prevented rLECs proliferation in vitro especially from
the 10th day after transfection. Thus, it might be used to
prevent PCO after cataract surgery.
In summary, this study has delineated the role of KLF6
in  inhibition  the  proliferation  of  rLECin  vitro.  Increased
expression of p21 and p27kip1 after transfection with KLF6
cDNA  suggest  their  important  role  for  inhibition  of  cell
proliferation. Our result may be the foundation for further
research on relation between KLF6 SV1 and proliferation of
LEC.
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